ANXA1 and cutaneous leishmaniasis: As FPR2 is an established downstream receptor of ANXA1, we aimed to assess the implication of the ANXA1/FPR2 receptor-ligand interaction in an in vivo model of experimental cutaneous leishmaniasis.